3 Min Read
LONDON (Thomson Reuters Foundation) - The world has missed ambitious goals to stem the spread of HIV and widen access to treatment, jeopardising a target to end the AIDS pandemic by 2030 unless global efforts are stepped up, the United Nations said on Thursday.
Last year, 84% of HIV-positive people knew they had the virus, with 87% of them taking antiretroviral drugs. Of those on medication, 90% had levels of the virus suppressed to a level so low it cannot be passed on, UNAIDS said in a report.
Targets of 90% by 2020 were set for each of the three goals five years ago, but the U.N. agency said global progress had been stymied by COVID-19.
The Premonition By Michael Lewis Highlights A Longstanding Need For Structural Reform Of The US Public Health Service forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
Billy Porter Reveals He Has Been H.I.V. Positive for 14 Years
The actor told The Hollywood Reporter that he had feared disclosing it would give “another way for people to discriminate against me in an already discriminatory profession.”
The Tony Award-winning actor Billy Porter told The Hollywood Reporter that he learned he had H.I.V. in 2007. He is shown here in 2014 watching a rehearsal of a play he wrote.Credit.Ruby Washington/The New York Times
May 19, 2021, 11:53 a.m. ET
The Tony and Emmy Award-winning actor Billy Porter disclosed in an interview with The Hollywood Reporter published on Wednesday that he learned he had H.I.V. in 2007 and hid the information from colleagues for over a decade, fearing discrimination in the entertainment industry.
John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs
A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.
John C. Martin in 2006 with a bottle of Truvada, a groundbreaking treatment for H.I.V. made by his company, Gilead Sciences, in the Bay Area. Credit.Paul Sakuma/Associated Press
April 27, 2021, 6:43 p.m. ET
John C. Martin, who became a billionaire by developing and marketing a daily single-dose pill that transformed H.I.V. into a manageable disease and who popularized another drug that cures hepatitis C, died on March 30 in Palo Alto, Calif. He was 69.